Search

Your search keyword '"B. Ho"' showing total 2,675 results

Search Constraints

Start Over You searched for: Author "B. Ho" Remove constraint Author: "B. Ho"
2,675 results on '"B. Ho"'

Search Results

1. Extensive mucocutaneous, oesophageal and otic lichen planus secondary to nivolumab therapy

6. Calibration of concomitant field offsets using phase contrast MRI for asymmetric gradient coils

7. Characterization by ENDOR Spectroscopy of the Iron–Alkyl Bond in a Synthetic Counterpart of Organometallic Intermediates in Radical SAM Enzymes

8. Prior Coronary Artery Bypass Graft Surgery Impacts 30-day Quality of Life after Percutaneous Coronary Intervention: Evidence from the Victorian Cardiac Outcomes Registry (VCOR)

9. 3D Bioprinted Osteochondral Plugs as a Potential Novel Treatment for Osteochondral Injuries

10. Enabling Prolonged Ocular Irrigation in Austere and Resource-Constrained Environments

11. A high-throughput in vitro method for assessing oxygen binding in native red blood cell suspensions

12. Noninvasive Assessment of Spinal Cord Injury in a Rat Model using Novel PET

14. Data from CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy

15. Supplementary Figure 2 from CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy

16. Supplementary Methods, Figure Legends 1-3 from CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy

17. Supplementary Figure 1 from CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy

18. Supplementary Figure 3 from CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy

20. Supplementary Materials from Targeting RNA Polymerase I with an Oral Small Molecule CX-5461 Inhibits Ribosomal RNA Synthesis and Solid Tumor Growth

21. Shiga Toxin (Stx) Type 1a and Stx2a Translocate through a Three-Layer Intestinal Model

25. On the mathematical structure of Einstein field equations and the existence of dark fields.

26. Measurement of the B s 0 → J / ψK S 0 $$ {\textrm{B}}_{\textrm{s}}^0\to \textrm{J}/{\uppsi \textrm{K}}_{\textrm{S}}^0 $$ effective lifetime from proton-proton collisions at s $$ \sqrt{s} $$ = 13 TeV

27. Measurement of differential ZZ + jets production cross sections in pp collisions at s $$ \sqrt{s} $$ = 13 TeV

28. Investigating carbonyl compounds above the Amazon rainforest using a proton-transfer-reaction time-of-flight mass spectrometer (PTR-ToF-MS) with NO+ chemical ionization

29. Forest Change Mapping using Multi-Source Satellite SAR, Optical, and LiDAR Remote Sensing Data

30. Measurement of beauty-quark production in pp collisions at s $$ \sqrt{s} $$ = 13 TeV via non-prompt D mesons

31. Observation of the $${{{\Lambda }} _{\text {b}}^{{0}}} \rightarrow {{\text {J}/\uppsi }} {{{\Xi }} ^{{-}}} {{\text {K}} ^{{+}}} $$ Λ b 0 → J / ψ Ξ - K + decay

32. Multiplicity dependence of charged-particle intra-jet properties in pp collisions at $$\sqrt{{{\varvec{s}}}}$$ s = 13 TeV

33. Search for Higgs boson pair production with one associated vector boson in proton-proton collisions at s $$ \sqrt{s} $$ = 13 TeV

34. Pilot study for the development of an automatically generated and wearable-based early warning system for the detection of deterioration of hospitalized patients of an acute care hospital

35. Search for a resonance decaying to a W boson and a photon in proton-proton collisions at s $$ \sqrt{s} $$ = 13 TeV using leptonic W boson decays

36. Investigating strangeness enhancement with multiplicity in pp collisions using angular correlations

37. Studying strangeness and baryon production mechanisms through angular correlations between charged Ξ baryons and identified hadrons in pp collisions at s $$ \sqrt{s} $$ = 13 TeV

38. Measurement of the background in the CMS muon detector in $${p}{p}$$ pp -collisions at $$\sqrt{s} = 13$$ s = 13 $$\,\text {Te}\hspace{-.08em}\text {V}$$ Te V

40. Additive Manufacturing for Fabrication of Point-of-Care Therapies in Austere Environments

41. Medical students’ perception of resilience and of an innovative curriculum-based resilience skills building course: a participant-focused qualitative analysis

45. Research Involving Participants With Impaired Consent Capacity

46. ECTRIMS 2021 – Late Breaking News ePoster

47. Coastal water bacteriophages infect various sets of

49. Accumulation and distribution of lead (Pb) in different tissues of Lucky bamboo plants (Dracaena sanderiana)

Catalog

Books, media, physical & digital resources